You're reading the free version. Trader adds the live tape and alerts.
Start tracking
STOK Sale Disclosure
Ticho Barry · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$49.69K
Ticho Barry Chief Medical Officer
STOK
Stoke Therapeutics
STOK
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
STOK daily price context
Close on/before transaction
$30.89
Sep 1, 2026
First close after public filing
$29.81
Sep 4, 2026
30-day return after filing
-15.06%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,600 shares @ $31.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780088-26-000021
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$170.06K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Stoke Therapeutics, Inc. STOK | Sale | Sep 1, 2026 | $120.37K |
| Stoke Therapeutics, Inc. STOK Current | Sale | Sep 1, 2026 | $49.69K |